hVIVO PLC | Income Statement

Fiscal year is January-December. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
27,490.00
18,472.00
7,717.00
19,850.00
10,878.00
11,025
Cost of Goods Sold (COGS) incl. D&A
19,177.00
12,999.00
5,266.00
15,629.00
7,316.00
8,901
Gross Income
8,313.00
5,473.00
2,451.00
4,221.00
3,562.00
2,124
SG&A Expense
9,721.00
27,773.00
23,870.00
20,049.00
17,448.00
14,507
EBIT
1,408.00
22,300.00
23,036.00
15,552.00
14,686.00
13,606
Unusual Expense
-
748.00
-
-
10.00
7,330
Non Operating Income/Expense
-
-
1,170.00
18.00
1,401.00
2,760
Interest Expense
11.00
15.00
-
-
-
-
Pretax Income
1,193.00
22,705.00
21,479.00
15,260.00
13,204.00
18,118
Income Tax
2,705.00
4,269.00
3,716.00
4,750.00
1,934.00
2,023
Equity in Affiliates
-
-
146.00
7,371.00
1,613.00
738
Consolidated Net Income
1,512.00
18,436.00
17,909.00
17,881.00
12,883.00
16,833
Net Income
1,512.00
18,436.00
17,909.00
17,881.00
12,883.00
16,833
Net Income After Extraordinaries
1,512.00
18,436.00
17,909.00
17,881.00
12,883.00
16,833
Net Income Available to Common
1,512.00
18,436.00
17,909.00
17,881.00
12,883.00
16,833
EPS (Basic)
0.03
0.31
0.26
0.23
0.16
0.21
Basic Shares Outstanding
47,963.20
58,839.40
68,943.60
78,076.40
78,141.10
78,992.40
EPS (Diluted)
0.03
0.31
0.26
0.23
0.16
0.21
Diluted Shares Outstanding
51,851.20
58,839.40
68,943.60
78,076.40
78,141.10
78,992.40
EBITDA
594.00
20,644.00
21,376.00
13,949.00
13,204.00
12,896
Other Operating Expense
-
-
1,617.00
276.00
800.00
1,223
Non-Operating Interest Income
226.00
358.00
387.00
310.00
71.00
58

About hVIVO

View Profile
Address
Queen Mary BioEnte Innovation Centre
London London & South East E1 2AX
United Kingdom
Employees -
Website http://retroscreen.com
Updated 07/08/2019
hVIVO Plc is an investment holding company, which engages in the provision of human-based analytical platform to accelerate drug discovery and development in respiratory and infectious diseases. It focuses on medical and scientific research services. The company was founded by John Sidney Oxford on March 27, 2012 and is headquartered in London, the United Kingdom.